{"transactions":[{"id":1366059,"date":"2\/25","real-date":1740044820,"title":"$165,000,000<\/strong>
Baby Bond
February 2025","content":"","role":"Co-Manager","company-name":"Oxford Lane Capital Coporation","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_900167290.png","alt":"diagram"}],"cta":{"title":"Read the Press Release","url":"https:\/\/ir.oxfordlanecapital.com\/news-market-data\/press-releases\/news-details\/2025\/Oxford-Lane-Capital-Corp.-Prices-Public-Offering-of-165000000-7.95-Notes-Due-2032\/default.aspx"},"filters":{"year":["2025"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1366068,"date":"2\/25","real-date":1740043800,"title":"$2,600,000<\/strong>
Follow-On Offering
February 2025","content":"","role":"Sole Book-Running Manager","company-name":"Intelligent Bio Solutions","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_757814459.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2025"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1367123,"date":"2\/25","real-date":1739894400,"title":"$300,000,000<\/strong>
Notes Offering
February 2025","content":"","role":"Co-Manager","company-name":"Sixth Street Specialty Lending","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_638052691.png","alt":"a white and blue sign"}],"cta":"","filters":{"year":["2025"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1360558,"date":"2\/25","real-date":1739456040,"title":"Acquisition of G5 Infrared
Fairness Opinion","content":"","role":"Financial Advisor","company-name":"LightPath Technologies","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_589504889.png","alt":"a white and black sign"}],"cta":"","filters":{"year":["2025"],"sectors":[1252005],"deal-types":[1252008]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1252008":{"id":1252008,"title":"Financial Advisory"}}},{"id":1348329,"date":"2\/25","real-date":1738631460,"title":"$6,100,000<\/strong>
At-the-Market Facility
February 2025","content":"","role":"Exclusive Sales Agent","company-name":"Calidi Biotherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_321418364.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2025"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1350971,"date":"1\/25","real-date":1738285860,"title":"$250,000,000<\/strong>
At-the-Market Facility
January 2025","content":"","role":"Co-Sales Agent","company-name":"SoundHound AI, Inc.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_218207832.png","alt":"shape"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-sales-agent-in-100-million-at-the-market-offering-for-ladenburg-acts-as-sales-agent-in-250-million-at-the-market-offering-for-soundhound-ai-inc"},"filters":{"year":["2025"],"sectors":[1252005],"deal-types":[1278100]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1315393,"date":"1\/25","real-date":1736902860,"title":"$4,250,000<\/strong>
Follow-On Offering
January 2025","content":"","role":"Exclusive Placement Agent","company-name":"Calidi Biotherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_963993507.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/calidi-biotherapeutics-closes-public-offering"},"filters":{"year":["2025"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1294309,"date":"12\/24","real-date":1733230020,"title":"$5,000,000<\/strong>
Follow-On Offering
December 2024","content":"Exclusive Warrant Agent","role":"Sole Book-Running Manager","company-name":"Palisade Bio","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_925108422.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/palisade-biotherapeutics-underwritten-public-offering"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1294307,"date":"12\/24","real-date":1733057220,"title":"$2,000,000,000<\/strong>
At-the-Market Facility
December 2024","content":"","role":"Sales Agent","company-name":"Oxford Lane Capital Coporation","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_900167290.png","alt":"diagram"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1278100]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1278023,"date":"11\/24","real-date":1731254520,"title":"$10,025,530<\/strong>
Follow-On Offering
November 2024","content":"","role":"Sole Book-Running Manager","company-name":"Autonomix","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_361668919.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/autonomix-underwritten-public-offering"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278099,"date":"11\/24","real-date":1730837340,"title":"$100,000,000<\/strong>
At-the-Market Facility
November 2024","content":"","role":"Sales Agent","company-name":"Chesapeake Utilities Corporation","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_497212750.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/chesapeake-utilities-100m-atm-offering"},"filters":{"year":["2024"],"sectors":[1252004],"deal-types":[1278100]},"sectors":{"1252004":{"id":1252004,"title":"Energy, Power & Infrastructure"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1278124,"date":"11\/24","real-date":1730736960,"title":"$7,500,000<\/strong>
Follow-On Offering
November 2024","content":"","role":"Exclusive Placement Agent","company-name":"Calidi Biotherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_911809426.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278127,"date":"11\/24","real-date":1730650980,"title":"$100,000,000<\/strong>
At-the-Market Facility
November 2024","content":"","role":"Sales Agent","company-name":"Serve Robotics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_856080062.jpg","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-sales-agent-in-100-million-at-the-market-offering-for-serve-robotics-inc"},"filters":{"year":["2024"],"sectors":[1252005],"deal-types":[1278100]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1278317,"date":"11\/24","real-date":1730621700,"title":"$3,848,285<\/strong>
Private Placement
November 2024","content":"","role":"Exclusive Warrant Solicitation Agent & Exclusive Placement Agent","company-name":"Nuwellis, Inc.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_508122645.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278365,"date":"11\/24","real-date":1730553780,"title":"$2,919,839<\/strong>
Private Placement
November 2024","content":"","role":"Exclusive Warrant Solicitation Agent & Exclusive Placement Agent","company-name":"Peraso","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_577746036.png","alt":"a group of blue and white letters"}],"cta":"","filters":{"year":["2024"],"sectors":[1252005],"deal-types":[1285702]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278443,"date":"10\/24","real-date":1727856900,"title":"$3,743,586<\/strong>
Private Placement
October 2024","content":"","role":"Exclusive Warrant Solicitation Agent & Exclusive Placement Agent","company-name":"Catheter Precision","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_936061684.png","alt":"text"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278637,"date":"10\/24","real-date":1727856900,"title":"$2,050,000<\/strong>
Registered Direct
October 2024","content":"","role":"Exclusive Placement Agent","company-name":"Calidi Biotherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_840561325.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278641,"date":"10\/24","real-date":1727770500,"title":"$5,100,000<\/strong>
At-The-Market Facility
October 2024","content":"","role":"Exclusive Sales Agent","company-name":"Calidi Biotherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_217058878.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1284410,"date":"9\/24","real-date":1727597700,"title":"$30,000,000<\/strong>
Baby Bond
September 2023","content":"","role":"Joint Book-Runner","company-name":"SWK Holdings","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_285438006.png","alt":"logo"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1284411,"date":"9\/24","real-date":1727511300,"title":"$1,965,094<\/strong>
Registered Direct
September 2023","content":"","role":"Exclusive Placement Agent","company-name":"Palisade Bio","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_780934304.png","alt":"logo"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278642,"date":"9\/24","real-date":1725437700,"title":"$26,000,000<\/strong>
Preferred Offering
September 2024","content":"","role":"Co-Manager ","company-name":"OFS Credit","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_425423424.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ofs-credit-26m-stock-offering"},"filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278648,"date":"9\/24","real-date":1725264900,"title":"$10,000,000<\/strong>
Non-Dilutive Financing
September 2024","content":"","role":"Exclusive Placement Agent","company-name":"Privately-Owned Vaccine Company","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_372436658.png","alt":"shape"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1324758]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1324758":{"id":1324758,"title":"Alternative Financing"}}},{"id":1278650,"date":"9\/24","real-date":1725239460,"title":"$11,500,000<\/strong>
Initial Public Offering
September 2024","content":"","role":"Lead Manager","company-name":"Legacy Education","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_141595315.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/legacy-education-11.5m-ipo"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278653,"date":"9\/24","real-date":1725178500,"title":"$3,000,000<\/strong>
At-the-Market Facility
September 2024","content":"","role":"Exclusive Sales Agent","company-name":"Intelligent BioSolutions","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_699487282.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1278656,"date":"8\/24","real-date":1725092040,"title":"$3,578,622<\/strong>
Follow-On Offering
August 2024","content":"","role":"Sole Book-Running Manager","company-name":"Catheter Precision","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_347978882.png","alt":"text"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-sole-book-running-manager-in-the-3.6-million-underwritten-public-offering-for-catheter-precision-inc"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278673,"date":"8\/24","real-date":1722906660,"title":"$1,425,000<\/strong>
At-the-Market Facility
August 2024","content":"","role":"Exclusive Sales Agent","company-name":"Peraso","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_652648491.png","alt":"a group of blue and white letters"}],"cta":"","filters":{"year":["2024"],"sectors":[1252005],"deal-types":[1278100]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1278675,"date":"8\/24","real-date":1722647460,"title":"$36,000,000<\/strong>
Baby Bond Offering
August 2024","content":"","role":"Co-Manager","company-name":"Great Elm Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_910081314.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278677,"date":"8\/24","real-date":1722586500,"title":"$891,782<\/strong>
Registered Direct
August 2024","content":"","role":"Exclusive Placement Agent","company-name":"Nuwellis","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_229461625.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278678,"date":"8\/24","real-date":1722500100,"title":"$460,000,000<\/strong>
Notes Offering
August 2024","content":"","role":"Co-Manager","company-name":"Core Scientific","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_634697914.png","alt":"icon"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-co-manager-in-the-460-million-notes-offering-for-core-scientific-inc"},"filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1278681,"date":"7\/24","real-date":1720080900,"title":"$3,870,515<\/strong>
Follow-On Offering
July 2024","content":"","role":"Sole Book-Running Manager","company-name":"Nova Bay Pharma","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_228575155.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-sole-bookrunning-manager-in-the-3.87-million-underwritten-public-offering-for-novabay-pharmaceuticals-inc"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1278682,"date":"7\/24","real-date":1719908100,"title":"$100,000,000<\/strong>
Baby Bond
July 2024","content":"","role":"Co-Manager","company-name":"Trinity Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_774198287.png","alt":"logo"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1278684,"date":"7\/24","real-date":1719821700,"title":"$5,009,968<\/strong>
Registered Direct
July 2024","content":"","role":"Exclusive Placement Agent ","company-name":"Boidexa Pharmaceuticals","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_901684557.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-sole-placement-agent-in-the-5-million-registered-direct-offering-for-biodexa-pharmaceuticals"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1283846,"date":"6\/24","real-date":1717575300,"title":"$100,000,000<\/strong>
Follow-On Offering
June 2024","content":"","role":"Co-Manager","company-name":"Oxford Lane","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_151294822.jpg","alt":"a black and white logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-co-manager-in-the-100-million-public-offering-for-oxford-lane-capital-corp"},"filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1283849,"date":"6\/24","real-date":1717492500,"title":"$3,394,200<\/strong>
Private Placement
June 2024","content":"","role":"Exclusive Warrant Solicitation Agent & Exclusive Placement Agent","company-name":"Sonnet BioTherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_456980182.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/sonnet-biotherapeutics-3.4m-offering"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1283850,"date":"6\/24","real-date":1717316100,"title":"$107,500,000<\/strong>
Follow-On Offering
June 2024","content":"","role":"Co-Manager","company-name":"UroGen Pharma","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_795086799.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-co-manager-in-the-107.5-million-offering-for-urogen-pharma-ltd"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1283851,"date":"6\/24","real-date":1717229700,"title":"$10,366,156<\/strong>
At-the-Market Facility
June 2024","content":"","role":"Exclusive Sales Agent","company-name":"Neonode","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_989459512.png","alt":"logo"}],"cta":"","filters":{"year":["2024"],"sectors":[1252005],"deal-types":[1278100]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1283862,"date":"5\/24","real-date":1714896900,"title":"$2,139,600<\/strong>
Private Placement
May 2024","content":"","role":"Exclusive Warrant Solicitation Agent & Exclusive Placement Agent","company-name":"Calidi Biotherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_906703406.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1283865,"date":"5\/24","real-date":1714724100,"title":"$75,000,000<\/strong>
At-the-Market Facility
May 2024","content":"","role":"Exclusive Sales Agent","company-name":"Jaguar Health","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_837586697.png","alt":"logo"}],"cta":"","filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1283866,"date":"5\/24","real-date":1714637700,"title":"$6,514,209<\/strong>
Private Placement
May 2024","content":"","role":"Exclusive Warrant Solicitation Agent & Exclusive Placement Agent","company-name":"Biodexa Pharmaceuticals","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_219068520.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/biodexa-6.5m-financing-and-acqusition-of-erapa"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1283867,"date":"5\/24","real-date":1714551300,"title":"$3,999,942<\/strong>
Private Placement
May 2024","content":"","role":"Exclusive Placement Agent","company-name":"Palisade Bio","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_737613196.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-in-the-4-million-private-placement-priced-at-the-market-under-nasdaq-rules-for-palisade-bio-inc"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1283868,"date":"4\/24","real-date":1712391300,"title":"$150,000,000<\/strong>
At-the-Market Facility
April 2024","content":"","role":"Sales Agent","company-name":"SoundHound","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_799900263.png","alt":"shape"}],"cta":"","filters":{"year":["2024"],"sectors":[1252005],"deal-types":[1278100]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1283870,"date":"4\/24","real-date":1712218500,"title":"$70,000,000<\/strong>
At-the-Market Facility
April 2024","content":"","role":"Sales Agent","company-name":"Gryphon Digital Mining","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_343851390.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252005],"deal-types":[1278100]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1283871,"date":"4\/24","real-date":1712045700,"title":"$6,079,000<\/strong>
Follow-On Offering
April 2024","content":"","role":"Exclusive Placement Agent","company-name":"Calidi Biotherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_944213366.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-sole-placement-agent-for-calidi-biotherapeutics-inc.in-their-6.1-million-public-offering"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1283872,"date":"4\/24","real-date":1711959300,"title":"$30,000,000<\/strong>
Baby Bond
April 2024","content":"","role":"Lead Book-Runner","company-name":"Great Elm Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_849638617.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-lead-bookrunner-for-great-elm-capital-corp.on-its-notes-offering-of-30.0-million"},"filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1283873,"date":"3\/24","real-date":1709367300,"title":"$30,500,000<\/strong>
Term Preferred
March 2024","content":"","role":"Lead Book-Runner","company-name":"Eagle Point Credit Company","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_179867943.png","alt":"text"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284371,"date":"3\/24","real-date":1709280900,"title":"$10,100,684<\/strong>
Private Placement
March 2024","content":"","role":"Exclusive Placement Agent","company-name":"Intelligent Bio Solutions","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_172490613.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/intelligent-bio-solutions-10.1m-private-placement"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284372,"date":"2\/24","real-date":1706918880,"title":"$650,000,000<\/strong>
Follow-On Offering
February 2024","content":"","role":"Co-Manager","company-name":"Pinnacle West Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_507682920.png","alt":"a black and white sign"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284373,"date":"2\/24","real-date":1706861700,"title":"$1,770,000<\/strong>
Private Placement
February 2024","content":"","role":"Exclusive Warrant Inducement Agent & Exclusive Placement Agent","company-name":"Intelligent Bio Solutions","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_757814459.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-in-the-1.77-million-warrant-exercise-transaction-for-intelligent-bio-solutions-inc"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284374,"date":"2\/24","real-date":1706775300,"title":"$4,172,000<\/strong>
Follow-On Offering
February 2024","content":"","role":"Sole Book-Running Manager","company-name":"Peraso, Inc.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_327504055.png","alt":"a group of blue and white letters"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/peraso-4.172m-underwritten-ipo"},"filters":{"year":["2024"],"sectors":[1252005],"deal-types":[1285702]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284375,"date":"1\/24","real-date":1704528900,"title":"$2,500,000<\/strong>
Private Placement
January 2024","content":"","role":"Exclusive Warrant Agent & Exclusive Placement Agent","company-name":"Palisade Bio","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_877263137.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-in-the-2.5-million-warrant-exercise-transaction-for-palisade-bio-inc"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284378,"date":"1\/24","real-date":1704442500,"title":"$2,950,000<\/strong>
Registered Direct
January 2024","content":"","role":"Sole Placement Agent","company-name":"Mobilicom Limited","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_315549331.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252005],"deal-types":[1285702]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284381,"date":"1\/24","real-date":1704356100,"title":"$50,000,000<\/strong>
Baby Bond
January 2024","content":"","role":"Joint Book-Runner","company-name":"Atlanticus","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_699791163.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1284384,"date":"1\/24","real-date":1704269700,"title":"$240,000,000<\/strong>
PIPE
January 2024","content":"","role":"Placement Agent","company-name":"Immuni Therapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_914677585.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-placement-agent-for-immunic-inc-in-private-placement-up-to-240-million"},"filters":{"year":["2024"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284389,"date":"1\/24","real-date":1704183300,"title":"$35,000,000<\/strong>
Term Preferred
January 2024","content":"","role":"Lead Book-Runner","company-name":"Eagle Point Credit Company","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_367649744.png","alt":"text"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284394,"date":"1\/24","real-date":1704096900,"title":"$350,000,000<\/strong>
Notes Offering
January 2024","content":"","role":"Co-Manager","company-name":"Sixth Street Specialty Lending","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_638052691.png","alt":"a white and blue sign"}],"cta":"","filters":{"year":["2024"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1281982,"date":"12\/23","real-date":1702982400,"title":"$6,000,000<\/strong> 
Follow-On Offering 
December 2023","content":"","role":"Sole Book-Running Manager","company-name":"Biodexa","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_138042496.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/biodexa-6m-underwritten-ipo"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1281967,"date":"12\/23","real-date":1701426480,"title":"$1,286,663 <\/strong>
Registered Direct \/ Private Placement 
December 2023","content":"","role":"Exclusive Placement Agent","company-name":"Cyclacel","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_252879494.png","alt":"a blue and white logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1282018,"date":"11\/23","real-date":1700045820,"title":"Exclusive License Agreement
November 2023","content":"","role":"Advisor to Biodexa","company-name":"Biodexa Pharmaceuticals Adhera Therapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_412961729.svg","alt":""},{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_196525171.png","alt":"logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1252011]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1252011":{"id":1252011,"title":"M & A"}}},{"id":1362484,"date":"11\/23","real-date":1699545600,"title":"$329,999,990<\/strong>
Follow-On Offering
November 2023","content":"","role":"Co-Manager","company-name":"Chesapeake Utilities","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_301884113.svg","alt":""}],"cta":"","filters":{"year":["2023"],"sectors":[1252004],"deal-types":[1285702]},"sectors":{"1252004":{"id":1252004,"title":"Energy, Power & Infrastructure"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1282005,"date":"11\/23","real-date":1698835740,"title":"$2,054,024<\/strong>
At-the-Market Facility
November 2023","content":"","role":"Exclusive Sales Agent","company-name":"Windtree Therapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_608313998.png","alt":"logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1282778,"date":"10\/23","real-date":1696602600,"title":"$4,378,000<\/strong>
Follow-On Offering
October 2023","content":"","role":"Sole Book-Running Manager","company-name":"Intelligent Bio Solutions","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_279571236.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-sole-book-running-manager-in-4.378-million-underwritten-public-offering-for-intelligent-bio-solutions-inc"},"filters":{"year":["2023"],"sectors":[1252005],"deal-types":[1285702]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1282104,"date":"10\/23","real-date":1696515900,"title":"$30,000,000<\/strong>
Term Preferred
October 2023","content":"","role":"Lead Book-Runner","company-name":"Carlyle Credit Income Fund","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_424042637.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-lead-bookrunner-for-carlyle-credit-income-fund-on-its-series-a-term-preferred-offering-of-30-million"},"filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1282091,"date":"10\/23","real-date":1696418280,"title":"$28,000,000<\/strong>
Private Placement
October 2023","content":"","role":"Exclusive Placement Agent","company-name":"enVVeno Medical","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_503578788.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-in-28-million-private-placement-for-envveno-medical"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1282089,"date":"10\/23","real-date":1696331700,"title":"$4,550,000<\/strong>
Follow-On Offering
October 2023","content":"","role":"Joint Book-Running Manager","company-name":"Sonnet BioTherapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_216251594.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/sonnet-biotherapeutics-4.55m-follow-on-offer"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1282088,"date":"10\/23","real-date":1696245180,"title":"$2,000,000 <\/strong>
Private Placement
October 2023","content":"","role":"Exclusive Placement Agent","company-name":"Coeptis Therapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_201890280.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/coeptis-therapeutics-2m-private-placement"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1282086,"date":"10\/23","real-date":1696158600,"title":"Merger Transaction 
October 2023","content":"","role":"Advisor to Aileron","company-name":"Aileron Therapeutics Lung Therapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_597885260.jpg","alt":"logo, company name"},{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_232166979.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/aileron-therapeutics-acquires-lung-therapeutics"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1252011]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1252011":{"id":1252011,"title":"M & A"}}},{"id":1284409,"date":"9\/23","real-date":1696061700,"title":"$50,000,000<\/strong>
Baby Bond
September 2023","content":"","role":"Joint Book-Runner","company-name":"PennyMac Loan Services","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_810264858.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1284413,"date":"9\/23","real-date":1695802500,"title":"Timber Pharmaceuticals Acquisition
by Leo Pharma
August 2023","content":"","role":"Joint Book-Runner","company-name":"Timber Pharmaceuticals a Leo Company","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_790684117.png","alt":"logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1252011]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1252011":{"id":1252011,"title":"M & A"}}},{"id":1284426,"date":"8\/23","real-date":1693296900,"title":"$82,500,000<\/strong>
Non-Dilutive Financing
August 2023","content":"","role":"Exclusive Financial Advisor & Placement Agent","company-name":"Ocular Therapeutix","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_840226585.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-exclusive-financial-advisor-to-ocular-therapeutix-inc.nasdaq-ocul-in-its-82.5-million-non-dilutive-financing"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1324758]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1324758":{"id":1324758,"title":"Alternative Financing"}}},{"id":1284415,"date":"8\/23","real-date":1693271460,"title":"Apexigen Acquired by
Pyxis Oncology
August 2023","content":"","role":"Advisor to Apexigen","company-name":"Apexigen","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_898838658.png","alt":"a black and white sign"},{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_195772288.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1252011]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1252011":{"id":1252011,"title":"M & A"}}},{"id":1284427,"date":"8\/23","real-date":1693210500,"title":"$35,000,000<\/strong>
Baby Bond
August 2023","content":"","role":"Joint Book-Runner","company-name":"Newtek One","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_437708100.png","alt":"logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1284539,"date":"8\/23","real-date":1693124100,"title":"$30,000,000<\/strong>
Baby Bond
August 2023","content":"","role":"Joint Book-Runner","company-name":"Whitehorse Finanace","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_716165950.png","alt":"logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1284548,"date":"8\/23","real-date":1693037700,"title":"$50,000,000<\/strong>
Baby Bond
August 2023","content":"","role":"Joint Book-Runner","company-name":"Gladstone Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_793707784.svg","alt":""}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1284565,"date":"8\/23","real-date":1692951300,"title":"$40,000,000<\/strong>
Baby Bond
August 2023","content":"","role":"Lead Book-Runner","company-name":"Great Elm Group","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_688827191.png","alt":"a logo with a green circle and text"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1284566,"date":"8\/23","real-date":1692864900,"title":"$300,000,000<\/strong>
Notes Offering
August 2023","content":"","role":"Co-Manager","company-name":"Sixth Street Specialty Lending","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_479126612.png","alt":"a white and blue sign"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1284569,"date":"8\/23","real-date":1692778500,"title":"$75,000,000<\/strong>
Follow-On Offering
August 2023","content":"","role":"Co-Manager","company-name":"Trinity Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_291527718.png","alt":"shape"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284582,"date":"7\/23","real-date":1690618500,"title":"$120,000,000<\/strong>
Private Placement
July 2023","content":"","role":"Financial Advisor","company-name":"UroGen Pharma","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_297616867.png","alt":"logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284584,"date":"7\/23","real-date":1690532100,"title":"$60,000,000<\/strong>
Follow-On Offering
July 2023","content":"","role":"Co-Manager","company-name":"Harrow Health, Inc.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_490286369.jpg","alt":"a blue and white sign"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-co-manager-for-harrow-in-its-60.0-million-public-offering"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1284589,"date":"7\/23","real-date":1690445700,"title":"$28,300,000<\/strong>
Term Preferred
July 2023","content":"","role":"Joint Book-Runner","company-name":"Eagle Point Credit Company","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_571180877.png","alt":"text"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-lead-bookrunner-for-eagle-point-income-company-inc.on-its-term-preferred-offering-of-28-million"},"filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1285690,"date":"7\/23","real-date":1690359300,"title":"$5,872,900<\/strong>
Registered Direct
July 2023","content":"","role":"Financial Advisor","company-name":"A2Z Smart Technologies Corp.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_386894867.png","alt":"circle"}],"cta":"","filters":{"year":["2023"],"sectors":[1252005],"deal-types":[1285702]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1285693,"date":"6\/23","real-date":1688112900,"title":"$225,000,000<\/strong>
Follow-On Offering
June 2023","content":"","role":"Lead Manager","company-name":"Axsome Therapeutics, Inc.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_349858279.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-lead-manager-for-axsome-therapeutics-in-its-225-million-public-offering"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1285695,"date":"6\/23","real-date":1688026500,"title":"$3,500,000<\/strong>
Follow-On Offering
June 2023","content":"","role":"Sole Book-Running Manager","company-name":"Coeptis Therapeutics","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_527939429.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-sole-book-running-manager-for-coeptis-therapeutics-in-its-3.5-million-underwritten-offering"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1285697,"date":"6\/23","real-date":1687940100,"title":"$71,875,000<\/strong>
Baby Bond
June 2023","content":"","role":"Joint Book-Running Manager","company-name":"Capital Southwest","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_405017280.jpeg","alt":"text"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1285699,"date":"6\/23","real-date":1687853700,"title":"$3,077,750<\/strong>
Registered Direct
June 2023","content":"","role":"Financial Advisor","company-name":"Auddia, Inc.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_636915334.jpg","alt":""}],"cta":"","filters":{"year":["2023"],"sectors":[1252005],"deal-types":[1285702]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1285703,"date":"6\/23","real-date":1687741680,"title":"$6,325,000<\/strong>
Follow-On Offering
June 2023","content":"","role":"Sole Book-Running Manager","company-name":"Kiora Pharmaceuticals","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_964746389.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-sole-book-running-manager-for-kiora-pharmaceuticals-inc.in-its-6.3-million-underwritten-public-offering"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1285700,"date":"5\/23","real-date":1685434500,"title":"$65,000,000<\/strong>
Baby Bond
May 2023","content":"","role":"Joint Book-Running Manager","company-name":"Gladstone Investment","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_376241411.svg","alt":""}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1285701,"date":"5\/23","real-date":1685348100,"title":"$47,738,785<\/strong>
RIghts Offering
May 2023","content":"","role":"Deal Manager","company-name":"Oxford Square Capital Corporation","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_760208932.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286330,"date":"5\/23","real-date":1685261700,"title":"$3,320,388<\/strong>
Registered Direct \/
Private Placement
May 2023
","content":"","role":"Exclusive Placement Agent","company-name":"Biodexa Pharmaceuticals","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_644404099.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-in-a-3.32-million-registered-direct-offering-for-biodexa-pharmaceuticals-plc"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286511,"date":"4\/23","real-date":1682583300,"title":"$12,420,000<\/strong>
Follow-On Offering
April 2023
","content":"","role":"Sole Book-Running Manager","company-name":"WINDTREE THERAPEUTICS","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_924755382.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-sole-book-running-manager-in-12.4-million-offering-for-windtree-therapeutics-inc"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286513,"date":"4\/23","real-date":1682496900,"title":"$3,000,000<\/strong>
Private Placement
April 2023
","content":"","role":"Exclusive Placement Agent","company-name":"NovaBay\u00ae<\/sup> PHARMA","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_801709866.svg","alt":""}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-in-3-million-private-placement-for-novabay-pharmaceuticals-inc"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286515,"date":"4\/23","real-date":1682410500,"title":"$50,000,000<\/strong>
Baby Bond
April 2023
","content":"","role":"Lead Book-Runner","company-name":"SARATOGA INVESTMENT CORP.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_316996714.png","alt":"a black and white sign"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1286516,"date":"4\/23","real-date":1682298300,"title":"$6,000,000<\/strong> 
Registered Direct \/ Private Placement 
April 2023  ","content":"","role":"Exclusive Placement Agent","company-name":"PALISADEBIO","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_283615085.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-in-6-million-registered-direct-and-private-placement-offerings-for-palisade-bio-inc"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286521,"date":"3\/23","real-date":1679965260,"title":"$60,000,000<\/strong>
Initial Public Offering
March 2023","content":"","role":"Joint Book-Runner","company-name":"Trailblazer Merger Corporation","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_920669336.jpeg","alt":"a green and white sign"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286522,"date":"3\/23","real-date":1679878920,"title":"$2,554,461<\/strong>
Follow-On Offering
March 2023","content":"","role":"Sole Book-Running Manager","company-name":"Intelligent BioSolutions","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_998211034.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-sole-book-running-manager-in-2.55-million-offering-for-intelligent-bio-solutions-inc"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286532,"date":"3\/23","real-date":1679818500,"title":"$4,400,000<\/strong>
At-the-Market Facility
March 2023","content":"","role":"Exclusive Sales Agent","company-name":"Nuwellis","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_380890473.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1286533,"date":"2\/23","real-date":1677291900,"title":"$5,000,000<\/strong>
At-the-Market Facility
February 2023","content":"","role":"Exclusive Sales Agent","company-name":"ORAGENICS","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_272610345.png","alt":"a blue and green logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1286543,"date":"2\/23","real-date":1677117720,"title":"$100,000,000<\/strong>
At-the-Market Facility
February 2023","content":"","role":"Lead Sales Agent","company-name":"META\u00ae<\/sup>","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_218927521.png","alt":"text"}],"cta":"","filters":{"year":["2023"],"sectors":[1252005],"deal-types":[1278100]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1286538,"date":"2\/23","real-date":1677117720,"title":"$189,400,000<\/strong>
Follow-On Offering
February 2023","content":"","role":"Co-Manager","company-name":"ESSENTIAL PROPERTIES","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_706233209.png","alt":""}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286550,"date":"2\/23","real-date":1677031320,"title":"$6,000,000<\/strong>
Private Placement
February 2023
","content":"","role":"Exclusive Placement Agent","company-name":"Midatech Pharma","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_280053326.jpeg","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-in-6-million-offering-for-midatech-pharma-plc"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286558,"date":"1\/23","real-date":1675040460,"title":"$47,200,000<\/strong>
Follow-On Offering
January 2023","content":"","role":"Co-Manager","company-name":"Pennant Park Floating Rate Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_586347307.jpeg","alt":"a black and white sign"}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286569,"date":"1\/23","real-date":1674980100,"title":"$869,600,000<\/strong>
Follow-On Offering
January 2023","content":"","role":"Co-Manager
","company-name":"VICI\u2122","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_675753255.png","alt":""}],"cta":"","filters":{"year":["2023"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286583,"date":"1\/23","real-date":1674867660,"title":"$20,000,000<\/strong>
Follow-On Offering
January 2023","content":"","role":"Financial Advisor","company-name":"KOPIN","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_642478195.jpg","alt":"logo, company name"}],"cta":"","filters":{"year":["2023"],"sectors":[1252005],"deal-types":[1285702]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286593,"date":"1\/23","real-date":1674781260,"title":"$1,000,000<\/strong>
Private Placement
January 2023","content":"","role":"Exclusive Warrant Inducement Agent","company-name":"WINDTREE THERAPEUTICS\u2122","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_309430845.png","alt":"logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1286595,"date":"1\/23","real-date":1674623520,"title":"Merger Transaction with
Catheter Precision
January 2023","content":"","role":"Advisor to Ra Medical Systems","company-name":"Ra Medical Systems","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_511283376.png","alt":"logo"},{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_943076839.png","alt":"text"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-exclusive-warrant-inducement-agent-in-ra-medicals-rmed-6.2m-warrant-repricing-and-announces-strategic-merger-plans-with-catheter-precision-inc"},"filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1252011]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1252011":{"id":1252011,"title":"M & A"}}},{"id":1286596,"date":"1\/23","real-date":1674536700,"title":"$9,326,432<\/strong>
Private Placement
January 2023","content":"","role":"Exclusive Warrant Inducement Agent & Exclusive Placement Agent","company-name":"Ra Medica Systems","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_902754848.png","alt":"logo"}],"cta":"","filters":{"year":["2023"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287208,"date":"12\/22","real-date":1672500360,"title":"$2,500,000<\/strong>
Registered Direct \/ Private Placement 
December 2022<\/strong>","content":"","role":"Exclusive Placement Agent ","company-name":"Palisade Bio","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_797088446.png","alt":"logo"}],"cta":"","filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287273,"date":"12\/22","real-date":1672362000,"title":"$52,500,000
<\/strong>Baby Bond
December 2022
","content":"","role":"Lead Book-Runner","company-name":"Saratoga Investment Corp","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_838270787.png","alt":"a black and white sign"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1287274,"date":"11\/22","real-date":1669773600,"title":"Fairness Opinion
November 2022","content":"","role":"Financial Advisor","company-name":"VallonPharma","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_131204151.jpeg","alt":"logo, company name"}],"cta":"","filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1252011]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1252011":{"id":1252011,"title":"M & A"}}},{"id":1287275,"date":"11\/22","real-date":1669338060,"title":"$45,000,000<\/strong>
Baby Bond
November 2022","content":"","role":"Joint Book-Runner","company-name":"Runway Growth Finance Corp","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_869697316.png","alt":"a black and white sign"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1287276,"date":"11\/22","real-date":1668906660,"title":"$40,000,000<\/strong>
Follow-On Offering
November 2022","content":"","role":"Co-Manager","company-name":"CSWC Capital Southwest","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_908241627.png","alt":"graphical user interface, application"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287277,"date":"11\/22","real-date":1668474060,"title":"$3,122,484<\/strong>
Private Placement
November 2022","content":"","role":"Exclusive Warrant Solicitation Agent","company-name":"Kiora Pharmaceuticals","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_917061566.jpg","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-warrant-solicitation-agent-in-3.12-million-offering-for-kiora-pharmaceuticals-inc"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287278,"date":"11\/22","real-date":1668214860,"title":"$32,250,000<\/strong>
Follow-On Offering and
Private Placement
November 2022","content":"","role":"Sole Book-Running Manager &
Exclusive Placement Agent","company-name":"NeuroBo Pharmaceuticals","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_658539206.jpg","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-sole-book-running-manager-and-exclusive-placement-agent-for-32-million-offering-for-neurobo-pharmaceuticals-inc"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287279,"date":"10\/22","real-date":1667178060,"title":"$40,000,000<\/strong>
Baby Bond
October 2022","content":"","role":"Lead Book-Runner","company-name":"Saratoga Investment Corp","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_905512889.png","alt":""}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1287280,"date":"10\/22","real-date":1666227660,"title":"$11,040,000<\/strong>
Follow-On Offering
October 2022","content":"","role":"Sole Book-Running Manager","company-name":"Nuwellis","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_872846891.png","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-sole-book-running-manager-for-nuwellis-inc.in-its-11.04-million-underwritten-public-offering-including-full-exercise-of-overallotment-option"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}}},{"id":1287281,"date":"10\/22","real-date":1665795660,"title":"Acquisition of
Intelligent Fingerprinting
October 2022","content":"","role":"Financial Advisor to GBS","company-name":"GBS","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_224100441.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-exclusive-financial-advisor-to-gbs-inc.in-its-acquisition-of-intelligent-fingerprinting"},"filters":{"year":["2022"],"sectors":[1252005],"deal-types":[1252011]},"sectors":{"1252005":{"id":1252005,"title":"Technology, Media & Telecom"}},"deal-types":{"1252011":{"id":1252011,"title":"M & A"}}},{"id":1287282,"date":"9\/22","real-date":1664499660,"title":"$50,000,000<\/strong>
Initial Public Offering
September 2022","content":"","role":"Sole Book-Runner","company-name":"Qomolangma Acquisition Corp.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_976415848.png","alt":"logo, company name"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287283,"date":"9\/22","real-date":1663635660,"title":"$124,800,000<\/strong>
Follow-On Offering
September 2022","content":"","role":"Manager","company-name":"Rhythm Pharmaceuticals","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_524819433.jpeg","alt":"a white sign with black text"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-manager-for-rhythm-pharmaceuticals-inc.in-its-124.8-million-public-offering"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287284,"date":"9\/22","real-date":1663203660,"title":"$7,600,000<\/strong>
At-the-Market Facility
September 2022","content":"","role":"Exclusive Sales Agent","company-name":"RaMedical Systems","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_752340989.jpeg","alt":"logo, company name"}],"cta":"","filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1287285,"date":"9\/22","real-date":1662771660,"title":"Fairness Opinion
License Agreement with
Dong-A ST","content":"","role":"","company-name":"NeuroBo Pharmaceuticals","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_360674474.jpg","alt":"logo, company name"}],"cta":"","filters":{"year":["2022"],"sectors":[1252001],"deal-types":[]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}}},{"id":1287286,"date":"9\/22","real-date":1662771660,"title":"$5,315,500<\/strong>
Private Placement
September 2022","content":"","role":"Exclusive Placement Agent & 
Exclusive Warrant Solicitation Agent","company-name":"NovaBay Pharma","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_970892624.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-acts-as-exclusive-placement-agent-and-exclusive-warrant-solicitation-agent-in-5.3-million-offering-for-novabay-pharmaceuticals-inc"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287287,"date":"8\/22","real-date":1661821260,"title":"$7,600,000<\/strong>
At-the-Market Facility
August 2022","content":"","role":"Exclusive Sales Agent","company-name":"NeuroMetrix","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_303692721.jpeg","alt":""}],"cta":"","filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1287288,"date":"8\/22","real-date":1661389260,"title":"$2,700,000<\/strong>
At-the-Market Facility
August 2022","content":"","role":"Exclusive Sales Agent","company-name":"Forte Biosciences, Inc","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_412520716.jpg","alt":"text"}],"cta":"","filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1287289,"date":"8\/22","real-date":1659921060,"title":"$55,000,000<\/strong>
Follow-On Offering
August 2022","content":"","role":"Co-Manager","company-name":"Trinity Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_947015748.png","alt":"logo"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287293,"date":"8\/22","real-date":1659489060,"title":"$13,800,000<\/strong>
Follow-On Offering
August 2022","content":"","role":"Sole Book-Running Manager","company-name":"Palisade Bio","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_469343490.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-sole-book-running-manager-for-palisade-bio-inc.in-its-13.8-million-underwritten-public-offering"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287294,"date":"8\/22","real-date":1659402660,"title":"$49,600,000<\/strong>
Follow-On Offering
August 2022","content":"","role":"Co-Manager","company-name":"Pennant Park Floating Rate Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_727385113.jpeg","alt":"a black and white sign"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287295,"date":"8\/22","real-date":1659316260,"title":"$262,200,000<\/strong>
Follow-On Offering
August 2022","content":"","role":"Co-Manager","company-name":"Essential Properties","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_167414989.png","alt":""}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287299,"date":"7\/22","real-date":1656724260,"title":"$6,216,700<\/strong>
Private Placement
July 2022","content":"","role":"Exclusive Warrant Inducement Agent","company-name":"RaMedical Systems","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_682537747.png","alt":"logo"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-exclusive-warrant-inducement-agent-in-ra-medicals-rmed-6.2m-warrant-repricing-and-announces-strategic-merger-plans-with-catheter-precision-inc"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287301,"date":"6\/22","real-date":1654218660,"title":"$60,000,000<\/strong>
Term Preferred
June 2022","content":"","role":"Lead Book-Runner","company-name":"Oxford Lane Capital Corp.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_829718807.jpg","alt":"a black and white logo"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287302,"date":"6\/22","real-date":1654045860,"title":"$25,000,000<\/strong>
Baby Bond
June 2022","content":"","role":"Joint Book-Runner","company-name":"Great Elm Group","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_986762933.png","alt":"a logo with a green circle and text"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1287305,"date":"5\/22","real-date":1651453860,"title":"$3,933,840<\/strong>
Registered Direct
May 2022","content":"","role":"Exclusive Placement Agent","company-name":"VallonPharma","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_575157431.jpeg","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-exclusive-placement-agent-for-vallon-pharmaceuticals-inc.vlon-in-its-3.9-million-registered-direct-offering"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287306,"date":"5\/22","real-date":1651366920,"title":"$2,005,682<\/strong>
Registered Direct
May 2022","content":"","role":"Exclusive Placement Agent","company-name":"PalisadeBio","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_357132723.png","alt":"logo"}],"cta":"","filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287310,"date":"4\/22","real-date":1648948260,"title":"$87,500,000<\/strong>
Unsecured Notes
April 2022","content":"","role":"Lead Book-Runner","company-name":"Saratoga Investment Corp.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_779668229.png","alt":"a black and white sign"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acted-as-lead-bookrunner-for-saratoga-investment-corp.on-its-87.5-million-offering-of-unsecured-notes"},"filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1287311,"date":"4\/22","real-date":1648861860,"title":"$50,000,000<\/strong>
Follow-On Offering
April 2022","content":"","role":"Co-Manager","company-name":"Trinity Capital","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_562427849.png","alt":"shape"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1285702]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287315,"date":"2\/22","real-date":1643764260,"title":"$12,100,000<\/strong>
Follow-On Offering
February 2022","content":"","role":"Sole Book-Running Manager","company-name":"RaMedical Systems","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_889674478.jpeg","alt":"logo, company name"}],"cta":{"title":"Read the Press Release","url":"\/press-release\/ladenburg-thalmann-acts-as-sole-book-running-manager-for-ra-medical-systems-inc.rmed-in-its-12.1-million-follow-on-offering"},"filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1285702]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"}}},{"id":1287316,"date":"2\/22","real-date":1643713260,"title":"$75,000,000<\/strong>
At-the-Market Facility
February 2022","content":"","role":"Exclusive Sales Agent","company-name":"Jaguar Health","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_972477487.png","alt":"logo"}],"cta":"","filters":{"year":["2022"],"sectors":[1252001],"deal-types":[1278100]},"sectors":{"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"}},"deal-types":{"1278100":{"id":1278100,"title":"At-the-Market Offering"}}},{"id":1287319,"date":"1\/22","real-date":1641172260,"title":"$75,000,000<\/strong>
Notes Offering
January 2022","content":"","role":"Co-Manager","company-name":"Saratoga Investment Corp.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_556550172.png","alt":"a black and white sign"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1287320,"date":"1\/22","real-date":1641085860,"title":"$87,000,000<\/strong>
Baby Bond
January 2022","content":"","role":"Lead Book-Runner","company-name":"Eagle Point","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_893992684.png","alt":"text"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}},{"id":1287321,"date":"1\/22","real-date":1640998860,"title":"$87,000,000<\/strong>
Baby Bond
January 2022","content":"","role":"Lead Book-Runner","company-name":"Oxford Lane Capital Corp.","ladenburgImg":{"imgSrc":"https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_864939196.svg","alt":"Ladenburg Thalmann & Co. Inc."},"companyLogos":[{"imgSrc":"https:\/\/transform.octanecdn.com\/fitLogo\/600x400\/https:\/\/octanecdn.com\/ladenburgcom\/ladenburgcom_575070391.jpg","alt":"a black and white logo"}],"cta":"","filters":{"year":["2022"],"sectors":[1252002],"deal-types":[1284580]},"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"}},"deal-types":{"1284580":{"id":1284580,"title":"Debt Offering"}}}],"year":["2025","2024","2023","2022"],"sectors":{"1252002":{"id":1252002,"title":"Yield-Oriented Equities (BDCs, REITs, CLOs)"},"1252001":{"id":1252001,"title":"Healthcare & Life Sciences"},"1252005":{"id":1252005,"title":"Technology, Media & Telecom"},"1252004":{"id":1252004,"title":"Energy, Power & Infrastructure"}},"deal-types":{"1285702":{"id":1285702,"title":"Equity Offering"},"1284580":{"id":1284580,"title":"Debt Offering"},"1252011":{"id":1252011,"title":"M & A"},"1278100":{"id":1278100,"title":"At-the-Market Offering"},"1324758":{"id":1324758,"title":"Alternative Financing"},"1252008":{"id":1252008,"title":"Financial Advisory"}}}